Vycor Medical, Inc. (VYCO)
OQB · Healthcare · Medical Devices
Closing price as of 2026-09-10 · Source: TEK2day Finance
Key Metrics
About Vycor Medical, Inc.
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company operates through two segments: Vycor Medical and NovaVision. Its Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation therapies targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a German-based partner. It primarily serves hospitals and medical professionals. The company was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. operates as a subsidiary of Fountainhead Capital Management Ltd.
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 514K | 417K | 459K | 418K |
| Gross Profit | 452K | 335K | 375K | 344K |
| Operating Income | 32K | (37K) | 46K | 7K |
| Net Income | 5K | (63K) | 20K | (22K) |
| Diluted EPS | $0.00 | N/A | $0.00 | $0.00 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 1.2M | 1.5M | 1.6M | 1.9M |
| Gross Profit | 1.1M | 1.3M | 1.4M | 1.6M |
| Operating Income | (307K) | 40K | (9K) | 34K |
| Net Income | (405K) | (70K) | (107K) | (72K) |
| Diluted EPS | $-0.02 | $-0.01 | $-0.01 | $-0.01 |